Glucocorticoid response elements were found within the bcl-X gene promoter regions [50, 51], and an increase in Bcl-xL expression at the protein and transcriptional levels mediated through glucocorticoid receptor signaling [52] was observed in C6 glioma cells after DEX treatment [52, 53]. This evidence concerns the gene BCL2L1 and glioma.